104 related articles for article (PubMed ID: 28796315)
21. Hypoxia in bone metastasis and osteolysis.
Todd VM; Johnson RW
Cancer Lett; 2020 Oct; 489():144-154. PubMed ID: 32561416
[TBL] [Abstract][Full Text] [Related]
22. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A.
Mu M; Zhang Q; Li J; Zhao C; Li X; Chen Z; Sun X; Yu J
Cell Death Differ; 2023 Nov; 30(11):2393-2407. PubMed ID: 37816999
[TBL] [Abstract][Full Text] [Related]
23. Modified Zhenwu Tang delays chronic renal failure progression by modulating oxidative stress and hypoxic responses in renal proximal tubular epithelial cells.
Zhang YY; Jin PP; Guo DZ; Bian D
Heliyon; 2024 May; 10(10):e31265. PubMed ID: 38803876
[TBL] [Abstract][Full Text] [Related]
24. Different Patterns of Vascularization in Preinvasive States and at the Initial Stages of Invasive Growth of the Neoplasms.
Karseladze AI
Bull Exp Biol Med; 2023 Dec; 176(2):216-223. PubMed ID: 38225515
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia- and Postirradiation reoxygenation-induced HMHA1/ARHGAP45 expression contributes to cancer cell invasion in a HIF-dependent manner.
Lee PWT; Suwa T; Kobayashi M; Yang H; Koseki LR; Takeuchi S; Chow CCT; Yasuhara T; Harada H
Br J Cancer; 2024 May; ():. PubMed ID: 38740970
[TBL] [Abstract][Full Text] [Related]
26. Series of Desloratadine Platinum(IV) Hybrids Displaying Potent Antimetastatic Competence by Inhibiting Epithelial-Mesenchymal Transition and Arousing Immune Response.
Zhang M; Chen Y; Liu Z; Liu M; Wang Q
J Med Chem; 2024 Feb; 67(3):2031-2048. PubMed ID: 38232132
[TBL] [Abstract][Full Text] [Related]
27. The contribution and mechanism of hypoxia/USP19/Beclin-1 feed-forward loop in cervical cancer.
Xu G; Chai S; Zhang R; Chen M; Fan X; Zhang Y; Cai C; Ge RL
Biophys J; 2024 May; ():. PubMed ID: 38773770
[TBL] [Abstract][Full Text] [Related]
28. Breaking a feedback loop: A reassessment of an investigator initiated OS-AID study.
Braune K; Hussain S; Lal R; Leibrand S; Lewis DM; O'Donnell S
Diabetes Obes Metab; 2024 Jan; 26(1):400-402. PubMed ID: 37795622
[No Abstract] [Full Text] [Related]
29. Assessing predictions of fitness effects of missense mutations in SUMO-conjugating enzyme UBE2I.
Zhang J; Kinch LN; Cong Q; Weile J; Sun S; Cote AG; Roth FP; Grishin NV
Hum Mutat; 2017 Sep; 38(9):1051-1063. PubMed ID: 28817247
[TBL] [Abstract][Full Text] [Related]
30. SUMOylation targeting mitophagy in cardiovascular diseases.
Xiao H; Zhou H; Zeng G; Mao Z; Zeng J; Gao A
J Mol Med (Berl); 2022 Nov; 100(11):1511-1538. PubMed ID: 36163375
[TBL] [Abstract][Full Text] [Related]
31. Protein Stability Regulation in Osteosarcoma: The Ubiquitin-like Modifications and Glycosylation as Mediators of Tumor Growth and as Targets for Therapy.
Di Gregorio J; Di Giuseppe L; Terreri S; Rossi M; Battafarano G; Pagliarosi O; Flati V; Del Fattore A
Cells; 2024 Mar; 13(6):. PubMed ID: 38534381
[TBL] [Abstract][Full Text] [Related]
32. Emerging role of SENP1 in tumorigenesis and cancer therapy.
Lin M; Zhang M; Yi B; Chen J; Wen S; Chen R; Chen T; Li Z
Front Pharmacol; 2024; 15():1354323. PubMed ID: 38389923
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis.
Zhou J; Lan F; Liu M; Wang F; Ning X; Yang H; Sun H
Front Pharmacol; 2024; 15():1350187. PubMed ID: 38327979
[TBL] [Abstract][Full Text] [Related]
34. SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1.
Xu X; Mao Y; Feng Z; Dai F; Gu T; Zheng J
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38186303
[TBL] [Abstract][Full Text] [Related]
35. Review on the protective mechanism of astragaloside IV against cardiovascular diseases.
Yang C; Pan Q; Ji K; Tian Z; Zhou H; Li S; Luo C; Li J
Front Pharmacol; 2023; 14():1187910. PubMed ID: 37251311
[TBL] [Abstract][Full Text] [Related]
36. KCNJ2/HIF1α positive-feedback loop promotes the metastasis of osteosarcoma.
Shen M; Pan R; Lei S; Zhang L; Zhou C; Zeng Z; Nie Y; Tian X
Cell Commun Signal; 2023 Mar; 21(1):46. PubMed ID: 36864422
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the Epithelial to Mesenchymal Transition in Osteosarcoma.
Hinton K; Kirk A; Paul P; Persad S
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830767
[TBL] [Abstract][Full Text] [Related]
38. SUMOylation in Skeletal Development, Homeostasis, and Disease.
Liu H; Craig SEL; Molchanov V; Floramo JS; Zhao Y; Yang T
Cells; 2022 Aug; 11(17):. PubMed ID: 36078118
[TBL] [Abstract][Full Text] [Related]
39. Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma.
Zhou Y; Li G; Li H; Lai F; Duan P; Cheng M
J Immunol Res; 2022; 2022():1377565. PubMed ID: 35836470
[TBL] [Abstract][Full Text] [Related]
40. SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy.
Yang Q; Yang M; Zhang J; Ma Y
Front Surg; 2021; 8():771785. PubMed ID: 35782332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
